Titelia

Funds holding LIGAND PHARMACEUTICALS INC

ISIN US53220K1997 · United States · LEI 5493008K7TB0IKP37H79

Fund holders
4
Of which ETFs
1 3 other funds
Value held
15.4K $
Share of capital
2.1 % of 19.9M shares on Aug 4, 2026

This issuer has other securities: Ligand Pharmaceuticals Inc (US53220K5048), LIGAND PHARMACEUTICALS INC (US53220K1732), LIGAND PHARMACEUTICALS INC (US53220K1815), LIGAND PHARMACEUTICALS INC (US53220K2151)

FundSharesValueWeight in fundShare of capital
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 395,81113.9K $1.99 %as of Jun 30, 2026 ↗
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 26,0871.4K $0.13 %as of May 31, 2026 ↗
Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust 1,53080.7 $0.01 %as of May 31, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 1,51880.1 $0.01 %as of May 31, 2026 ↗

Download this table: CSV, JSON

Report an error

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q340424,9460.0 %
2026Q240424,9460.0 %
2026Q140424,9460.0 %
2025Q440424,9460.0 %
2025Q340424,9460.0 %
2025Q240424,9460.0 %
2025Q140424,9460.0 %
2024Q440424,9460.0 %
2024Q340424,9460.0 %
2024Q240424,9460.0 %
2024Q140424,9460.0 %
2023Q44424,946

Funds holding the debt of LIGAND PHARMACEUTICALS INC

53 funds declare 63 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.

FundBond linesValue
iShares Convertible Bond ETF232M $as of Jul 31, 2026
State Street(R) SPDR(R) Bloomberg Convertible Securities ETF217.2M $as of Jun 30, 2026
Calamos Market Neutral Income Fund216M $as of Jul 31, 2026
Calamos Growth & Income Fund115M $as of Jul 31, 2026
Virtus Income & Growth Fund214.9M $as of Jun 30, 2026
Virtus Convertible Fund214.6M $as of Jun 30, 2026
Calamos Convertible Fund112.5M $as of Jul 31, 2026
ABSOLUTE CONVERTIBLE ARBITRAGE FUND19.9M $as of Jun 30, 2026
Columbia Convertible Securities Fund18.7M $as of May 31, 2026
Invesco Convertible Securities Fund16.5M $as of Jun 30, 2026
Calamos Global Opportunities Fund15.7M $as of Jul 31, 2026
WESTWOOD ALTERNATIVE INCOME FUND14M $as of Jul 31, 2026
Fidelity Convertible Securities Fund13.4M $as of May 31, 2026
Putnam Convertible Securities Fund12.7M $as of Jul 31, 2026
Calamos Global Convertible Fund12M $as of Jul 31, 2026
Loomis Sayles Strategic Income Fund11.4M $as of Jun 30, 2026
Fidelity Strategic Dividend and Income Fund11.2M $as of May 31, 2026
Empower High Yield Bond Fund11.1M $as of Jun 30, 2026
First Trust SSI Strategic Convertible Securities ETF21M $as of Jul 31, 2026
Loomis Sayles Investment Grade Bond Fund11M $as of Jun 30, 2026
JNL Multi-Manager Alternative Fund2799.4K $as of Jun 30, 2026
Bridge Builder Core Plus Bond Fund1569.4K $as of Jun 30, 2026
Voya Global Income & Growth Fund1518.2K $as of May 31, 2026
Empower Core Strategies: Flexible Bond Fund1367.7K $as of Jun 30, 2026
Empower Multi-Sector Bond Fund2358.8K $as of Jun 30, 2026
Cite this page

Titelia. "Funds holding LIGAND PHARMACEUTICALS INC". https://titelia.com/en/stocks/ligand-pharmaceuticals-inc-US53220K1997